Literature DB >> 22706007

The evolving epidemiology of HIV/AIDS.

Kevin M De Cock1, Harold W Jaffe, James W Curran.   

Abstract

Following its recognition in 1981, the HIV/AIDS epidemic has evolved to become the greatest challenge in global health, with some 34 million persons living with HIV worldwide. Early epidemiologic studies identified the major transmission routes of the virus before it was discovered, and enabled the implementation of prevention strategies. Although the first identified cases were in MSM in the United States and western Europe, the greatest impact of the epidemic has been in sub-Saharan Africa, where most of the transmission occurs between heterosexuals. Nine countries in southern Africa account for less than 2% of the world's population but now they represent about one third of global HIV infections. Where broadly implemented, HIV screening of donated blood and antiretroviral treatment (ART) of pregnant women have been highly effective in preventing transfusion-associated and perinatally acquired HIV, respectively. Access to sterile equipment has also been a successful intervention for injection drug users. Prevention of sexual transmission has been more difficult. Perhaps the greatest challenge in terms of prevention has been in the global community of MSM in which HIV remains endemic at high prevalence. The most promising interventions are male circumcision for prevention of female-to-male transmission and use of ART to reduce infectiousness, but the extent to which these interventions can be brought to scale will determine their population-level impact.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706007     DOI: 10.1097/QAD.0b013e328354622a

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  68 in total

1.  High HIV prevalence and incidence among MSM across 12 cities in India.

Authors:  Sunil S Solomon; Shruti H Mehta; Aylur K Srikrishnan; Canjeevaram K Vasudevan; Allison M Mcfall; Pachamuthu Balakrishnan; Santhanam Anand; Panneerselvam Nandagopal; Elizabeth L Ogburn; Oliver Laeyendecker; Gregory M Lucas; Suniti Solomon; David D Celentano
Journal:  AIDS       Date:  2015-03-27       Impact factor: 4.177

2.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.

Authors:  David S Metzger; Deborah Donnell; David D Celentano; J Brooks Jackson; Yiming Shao; Apinun Aramrattana; Liu Wei; Liping Fu; Jun Ma; Gregory M Lucas; Marek Chawarski; Yuhua Ruan; Paul Richardson; Katherine Shin; Ray Y Chen; Jeremy Sugarman; Bonnie J Dye; Scott M Rose; Geetha Beauchamp; David N Burns
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

3.  Predictors of medication adherence among HIV-positive women in North America.

Authors:  Lynda A Tyer-Viola; Inge B Corless; Alison Webel; Paula Reid; Kathleen M Sullivan; Patrice Nichols
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2014-02-06

Review 4.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

Review 5.  Concentrated HIV subepidemics in generalized epidemic settings.

Authors:  Frank Tanser; Tulio de Oliveira; Mathieu Maheu-Giroux; Till Bärnighausen
Journal:  Curr Opin HIV AIDS       Date:  2014-03       Impact factor: 4.283

6.  Communication Between Middle SES Black Women and Healthcare Providers About HIV Testing.

Authors:  Niasha A Fray; Kia Lilly Caldwell
Journal:  J Natl Med Assoc       Date:  2017-02-13       Impact factor: 1.798

7.  The causal effect of opioid substitution treatment on HAART medication refill adherence.

Authors:  Bohdan Nosyk; Jeong E Min; Guillaume Colley; Viviane D Lima; Benita Yip; M-J S Milloy; Evan Wood; Julio S G Montaner
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

8.  An essential role of antibodies in the control of Chikungunya virus infection.

Authors:  Fok-Moon Lum; Teck-Hui Teo; Wendy W L Lee; Yiu-Wing Kam; Laurent Rénia; Lisa F P Ng
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

9.  New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.

Authors:  Zhao Dang; Phong Ho; Lei Zhu; Keduo Qian; Kuo-Hsiung Lee; Li Huang; Chin-Ho Chen
Journal:  J Med Chem       Date:  2013-02-20       Impact factor: 7.446

10.  Risk factors for esophageal cancer in a high-incidence area of Malawi.

Authors:  Anja L Geßner; Angelika Borkowetz; Torsten J Wilhelm; Enock Ludzu; Michael Baier; Yamikani Mastala; Saulos Nyirenda; Henning Mothes
Journal:  Cancer Causes Control       Date:  2021-08-03       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.